Psychedelic Toad Venom Clinical Research Boosted by $80M in Funding
The psychedelic toad venom has been gaining traction as a treatment option for life-threatening diseases, but its clinical development was only recently boosted by $80M in funding. The new project will explore the use of psilocybin combined with chemotherapy and other treatments on psychiatric illnesses such as anxiety and depression. High Times is a magazine […]
Psychedelic Toad Venom Clinical Research Boosted by $80M in Funding Read More »